John Forbes
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies 79
- Oncology top 0.1%
- Cancer Treatment and Pharmacology 22
- HER2/EGFR in Cancer Research 19
- Cancer Risks and Factors 16
- Genetics top 0.1%
- Estrogen and related hormone effects 62
- Family Practice top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Advanced Breast Cancer Therapies 21
-
- Acute Ischemic Stroke Management 14
-
- Health Systems, Economic Evaluations, Quality of Life 13
- Co-authors
- Jack CuzickAnthony HowellMitch DowsettIvana ŠestakAman U. BuzdarAlan S. CoatesMichael BaumAron Goldhirsch
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- Journal of Clinical Oncology (36 papers)The Lancet (12 papers)Annals of Oncology (11 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
John Forbes
197 papers receiving 15.9k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Cancer Research 6.7k
- Oncology 8.2k
- Genetics 5.9k
- Family Practice 282
- Pulmonary and Respiratory Medicine 3.2k
Countries citing papers authored by John Forbes
This map shows the geographic impact of John Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Forbes more than expected).
Fields of papers citing papers by John Forbes
This network shows the impact of papers produced by John Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Forbes. The network helps show where John Forbes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Forbes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2021 | 16 | |
| 5 | 2021 | 4 | |
| 6 | 2019 | 23 | |
| 7 | 2017 | 31 | |
| 8 | 2013 | 12 | |
| 9 | 2012 | 102 | |
| 10 | Use of the pictorial Epworth Sleepiness Scale in adults with Down's syndrome | 2012 | 1 |
| 11 | 2011 | 50 | |
| 12 | 2011 | 2 | |
| 13 | 2010 | 55 | |
| 14 | Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategybreakdown → | 2010 | 402 |
| 15 | Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifenbreakdown → | 2009 | 581 |
| 16 | 2007 | 93 | |
| 17 | 2007 | 106 | |
| 18 | 2005 | 117 | |
| 19 | 1980 | 2 | |
| 20 | 1978 | 22 |
About John Forbes
John Forbes is a scholar working on Cancer Research, Oncology and Genetics, having authored 202 papers that have together received 16.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (79 papers), Estrogen and related hormone effects (62 papers), Cancer Treatment and Pharmacology (22 papers), Advanced Breast Cancer Therapies (21 papers), HER2/EGFR in Cancer Research (19 papers), Cancer Risks and Factors (16 papers), Acute Ischemic Stroke Management (14 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). The work is most often cited by research in Cancer Research (6.7k citations), Oncology (8.2k citations) and Genetics (5.9k citations). John Forbes has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Jack Cuzick, Anthony Howell, Mitch Dowsett, Ivana Šestak, Aman U. Buzdar, Alan S. Coates, Michael Baum, Aron Goldhirsch, Beat Thürlimann and Richard D. Gelber. Their work appears in journals such as Journal of Clinical Oncology, The Lancet, Annals of Oncology, The Lancet Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.